Previous close | 251.31 |
Open | 252.13 |
Bid | 257.00 x 800 |
Ask | 258.65 x 900 |
Day's range | 251.54 - 257.55 |
52-week range | 248.41 - 319.76 |
Volume | |
Avg. volume | 1,011,448 |
Market cap | 37.243B |
Beta (5Y monthly) | 0.13 |
PE ratio (TTM) | 13.80 |
EPS (TTM) | 18.63 |
Earnings date | 23 Oct 2023 - 27 Oct 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 333.66 |
Many retirees are no doubt anxiously awaiting to find out how much their Social Security benefits will increase in 2024. There's another question for which they still don't have an answer: How much will Medicare Part B premiums increase next year? The Centers for Medicare and Medicaid Services (CMS) typically announces the Medicare Part B premiums for the next year sometime between mid-October and early November.
Biogen Inc. (BIIB) closed at $252.86 in the latest trading session, marking a -1.61% move from the prior day.
It has been one of the most talked about biotechs in recent years, but that's not enough to make its shares a buy.